Ipilimumab for previously untreated unresectable malignant melanoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

Ros Wade; Christina Dimitra Giannopoulou; Eleftherios Sideris; Thirimon Moe-Byrne; Melissa Harden; Claire Rothery; Alison Jane Eastwood

Ipilimumab for previously untreated unresectable malignant melanoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

Ros Wade, Christina Dimitra Giannopoulou, Eleftherios Sideris, Thirimon Moe-Byrne, Melissa Harden, Claire Rothery, Alison Jane Eastwood

Research output: Book/Report › Commissioned report

Original language	English
Publisher	National Institute for Health and Care Excellence
Commissioning body	National Institute for Health Research (NIHR)
Publication status	Published - 2013

Access to Document

https://www.nice.org.uk/guidance/ta319/history

Cite this

@book{b032b9d0449941d5bcfc89f56e96b68a,

title = "Ipilimumab for previously untreated unresectable malignant melanoma. Evidence Review Group Report for the National Institute for Health and Care Excellence",

author = "Ros Wade and Giannopoulou, {Christina Dimitra} and Eleftherios Sideris and Thirimon Moe-Byrne and Melissa Harden and Claire Rothery and Eastwood, {Alison Jane}",

year = "2013",

language = "English",

publisher = "National Institute for Health and Care Excellence",

}

TY - BOOK

T1 - Ipilimumab for previously untreated unresectable malignant melanoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

AU - Wade, Ros

AU - Giannopoulou, Christina Dimitra

AU - Sideris, Eleftherios

AU - Moe-Byrne, Thirimon

AU - Harden, Melissa

AU - Rothery, Claire

AU - Eastwood, Alison Jane

PY - 2013

Y1 - 2013

M3 - Commissioned report

BT - Ipilimumab for previously untreated unresectable malignant melanoma. Evidence Review Group Report for the National Institute for Health and Care Excellence

PB - National Institute for Health and Care Excellence

ER -